IRF4 and cholesteryl ester measurement: One promising diagnostic tool for IHC is dual immunohistochemistry for CD138, while the multiple myeloma oncogene 1 (MUM-1) has also been suggested as a possible marker, with the main disadvantage of this method being that the lower limit of plasma cells per tissue sample has not been established in order to safely diagnose CE [27].